FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

19475611000001106: Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65839401000001117 Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65839501000001118 Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Is a Rifaximin 200mg tablets 9 tablet true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has AMP Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has specific active ingredient Rifaximin true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xifaxanta 200mg tablets (Norgine Pharmaceuticals Ltd) 9 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start